|
UTHR
|
US |
UNITED THERAPEUTICS CORP |
2,760,300 |
$974M |
13.78% |
-3.4%
|
- |
|
ARGX
|
US |
ARGENX SE - ADR |
1,238,467 |
$762M |
10.77% |
-
|
- |
|
ASND
|
US |
ASCENDIS PHARMA A/S - ADR |
5,103,055 |
$703M |
9.94% |
2.3%
|
- |
|
MDGL
|
US |
MADRIGAL PHARMACEUTICALS INC |
2,029,000 |
$626M |
8.86% |
-
|
- |
|
KRYS
|
US |
KRYSTAL BIOTECH INC |
2,628,822 |
$412M |
5.83% |
0.3%
|
- |
|
APLS
|
US |
APELLIS PHARMACEUTICALS INC |
12,222,222 |
$390M |
5.52% |
10.0%
|
- |
|
SRPT
|
US |
SAREPTA THERAPEUTICS INC |
2,555,555 |
$311M |
4.40% |
-
|
- |
|
ITCI
|
US |
INTRA-CELLULAR THERAPIES INC |
3,050,000 |
$255M |
3.60% |
-
|
- |
|
VERA
|
US |
VERA THERAPEUTICS INC |
5,610,000 |
$237M |
3.36% |
30.2%
|
- |
|
XENE
|
US |
XENON PHARMACEUTICALS INC |
5,666,666 |
$222M |
3.14% |
-
|
- |
|
FOLD
|
US |
AMICUS THERAPEUTICS INC |
23,175,000 |
$218M |
3.09% |
-
|
- |
|
RNA
|
US |
AVIDITY BIOSCIENCES INC |
7,500,000 |
$218M |
3.08% |
9.1%
|
- |
|
ARWR
|
US |
ARROWHEAD PHARMACEUTICALS IN |
11,111,111 |
$209M |
2.95% |
25.0%
|
- |
|
KYMR
|
US |
KYMERA THERAPEUTICS INC |
5,150,000 |
$207M |
2.93% |
14.4%
|
- |
|
MLTX
|
US |
MOONLAKE IMMUNOTHERAPEUTICS |
2,770,100 |
$150M |
2.12% |
-
|
- |
|
SLNO
|
US |
SOLENO THERAPEUTICS INC |
2,525,000 |
$113M |
1.61% |
15.8%
|
- |
|
BPMC
|
US |
BLUEPRINT MEDICINES CORP |
1,185,000 |
$103M |
1.46% |
100.0%
|
- |
|
PCVX
|
US |
VAXCYTE INC |
1,175,000 |
$96M |
1.36% |
-
|
- |
|
BMRN
|
US |
BIOMARIN PHARMACEUTICAL INC |
1,462,500 |
$96M |
1.36% |
-28.2%
|
- |
|
BCRX
|
US |
BIOCRYST PHARMACEUTICALS INC |
11,865,000 |
$89M |
1.26% |
-
|
- |